← Open Payments lookup

CHIEMEZIE OKONKO: Open Payments

NPI 1881247229 · INGLEWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,752 in 57 payments from 13 companies in 2025. Trend: 2023 $1,223 · 2024 $1,467 · 2025 $2,752

Food & beverage: $2,529Education: $223
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.26$944
Janssen Pharmaceuticals, Inc9$652
Otsuka America Pharmaceutical, Inc.6$231
Braeburn Inc.4$190
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$171
Alkermes, Inc.1$123
Axsome Therapeutics, Inc.1$123
Janssen Biotech, Inc.1$123
Novo Nordisk Inc1$105
E.R. Squibb & Sons, L.L.C.1$25

Products named: UZEDY, INVEGA SUSTENNA, SPRAVATO, BRIXADI, CAPLYTA, REXULTI, LYBALVI, Auvelity.

Industry payments across CA — which companies pay providers there.